Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02610751 · ClinicalTrials.gov registry record
Maternal Smoking During Pregnancy and Female Fetal Testosterone Levels
A clinical trial, sponsored by TriHealth.
- Completed
- Registry status
- 80
- Enrollment target
NCT02610751: Completed study, sponsored by TriHealth.
NCT02610751 is a clinical trial that has completed, run by TriHealth. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02610751 has completed, sponsored by TriHealth.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
* The investigators hope their study will answer the question of whether or not fetal testosterone levels are increased in female newborns exposed to nicotine as a result of maternal smoking during pregnancy. Secondarily they plan to also evaluate maternal cotinine and testosterone levels and newborn anogenital distance, second digit to fourth digit (2D:4D) finger length ratio, newborn length and birth weight. * The investigators hope by performing this study, they will help to uncover the effect of tobacco exposure in utero on human female fetal testosterone levels, thus improving the counseling for tobacco use in pregnancy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2016-01 |
| Est. Completion | 2019-08-26 |
What the finished NCT02610751 record still lists
NCT02610751 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02610751 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02610751 about?
NCT02610751 is a clinical study titled "Maternal Smoking During Pregnancy and Female Fetal Testosterone Levels". * The investigators hope their study will answer the question of whether or not fetal testosterone levels are increased in female newborns exposed to nicotine as a result of maternal smoking during pregnancy. Secondarily they plan to also evaluate maternal cotinine and testosterone levels and newbor...
What is the current status of trial NCT02610751?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2016-01. Estimated completion is 2019-08-26.
Who is sponsoring clinical trial NCT02610751?
This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia